Target intelligence / Profile preview

Thyrotropin-releasing hormone receptor 1 (TRHR1)

Target
TRHR1
Molecular classification
G protein-coupled receptor, Rhodopsin-like GPCR, Receptor, 7-transmembrane receptor
01

Overview

Thyrotropin-releasing hormone receptor 1 (TRHR1) is a Class A G protein-coupled receptor that serves as the primary mediator for the actions of thyrotropin-releasing hormone (TRH). It is predominantly expressed in the anterior pituitary gland and throughout the central nervous system, including the hypothalamus, brainstem, and spinal cord. In the pituitary, TRHR1 activation stimulates the release of thyroid-stimulating hormone (TSH) and prolactin, thereby playing a central role in the hypothalamic-pituitary-thyroid axis and metabolic regulation. Beyond its endocrine functions, TRHR1 acts as a neuromodulator in the brain, influencing arousal, motor control, and thermogenesis. Clinically, TRHR1 is targeted by agonists like protirelin for diagnostic thyroid testing and by synthetic analogs such as taltirelin for the treatment of neurodegenerative disorders like spinocerebellar ataxia. The receptor is also being investigated for its potential neuroprotective roles in spinal cord injury and various psychiatric conditions.

Other names
TRH-RTRHRThyroliberin receptorTRH receptor type 1Thyrotropin-releasing hormone receptor
02

Mechanism of action

Agonism of the TRHR1 receptor activates the Gq/11-phospholipase C (PLC) signaling pathway, leading to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). This cascade triggers the release of intracellular calcium and activation of protein kinase C (PKC), which in the pituitary stimulates the secretion of thyroid-stimulating hormone (TSH) and prolactin. In the central nervous system, this activation modulates neurotransmitter release and provides neuroprotective effects.

03

Biological functions

Signal transductionHormone secretionRegulation of thyroid functionNeurotransmissionNeuromodulationThermogenesisFeeding behaviorWater intake
04

Disease associations

HypothyroidismHyperthyroidismSpinocerebellar degenerationDepressionEpilepsyAlzheimer's diseaseParkinson's diseaseSpinal cord injuryAcute myeloid leukemia
05

Safety considerations

Cardiovascular effects (tachycardia, hypertension)Gastrointestinal distress (nausea, vomiting)FlushingUrinary urgencyHormonal imbalances (hyperthyroidism symptoms)Short half-life of native ligands
06

Interacting drugs

Protirelin

5 more in the full profile.

07

Biomarkers

Thyroid-stimulating hormone (TSH)ProlactinTRH stimulation testTRH mRNA expression

Beyond the preview

Go deeper on Thyrotropin-releasing hormone receptor 1 (TRHR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thyrotropin-releasing hormone receptor 1 (TRHR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call